Substance Use Disorder Awareness and Education

This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.

These principles from the CDC are intended to help public health professionals, particularly health communicators, within and outside of CDC ensure their communication products and strategies adapt to the specific cultural, linguistic, environmental, and historical situation of each population or audience of focus.

This page offers background information and tips for providers to keep in mind while using person-first language, as well as terms to avoid to reduce stigma and negative bias when discussing addiction.

This page from SAMHSA's Office of Behavioral Health Equity includes information on the drivers of behavioral health inequities and resources for several underrepresented populations.

To help key stakeholders understand and differentiate digital therapeutics from the thousands of other mobile health apps that are available, this library highlights evidence-based innovative digital therapeutics products.

This webpage includes a list of VA mobile apps which provide support and guidance in living with PTSD, help with related issues affecting people with PTSD, and additional help for PTSD treatments.

This website provides information, videos, training, and other resource information for implementing technology assisted treatments/care to improve the quality and reach of treatment services for persons with substance use disorders.

This website provides evaluations for mental health apps, including those related to substance use, based on app credibility, user experience, and transparency of privacy practices.

This webpage provides a library of mental health apps, including those related to substance use, and provides evaluations based on the American Psychiatric Association's App Evaluation Model.

This worksheet provides recommendations for patients, clinicians, and payors, on how to ensure digital therapeutic quality, access, and utilization when considering mental health apps, including those for substance use.